Syk inhibitors (Voltarra)

N/A

Report date: 2025/03/20 15:21:18
NME

Base Information

Drug NameSyk inhibitors (Voltarra)
Drug Alias Namespleen tyrosine kinase inhibitors (IMC Biotechnology)Syk inhibitors (IMC Biotechnology)spleen tyrosine kinase inhibitors (Voltarra)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIMC Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesLevolta Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsArthritis, RheumatoidNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A